These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 967362)

  • 1. [Evaluation of the changes in some laboratory parameters in liver disease patients treated with Toxepasi Complex].
    Lenzi S
    Minerva Med; 1976 Sep; 67(46):2961-74. PubMed ID: 967362
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Influence of UDPG, glutathione and vitamin B 12 therapy on various liver function indices in patients with liver cirrhosis].
    Coltorti M
    Clin Ter; 1975 Feb; 72(4):323-35. PubMed ID: 1222512
    [No Abstract]   [Full Text] [Related]  

  • 3. [The use of different liver-protective substances in the course of antitubercular chemotherapy and their effectiveness in preventing and countering the appearance of metabolic and functional liver changes Clinico-statistical studies].
    Natale F; Perna G
    Arch Sci Med (Torino); 1979; 136(4):591-6. PubMed ID: 550759
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Uridine diphosphate glucose in acute viral hepatitis].
    Crispo C; Perruna F; Di Nicuolo G; Rosiello A
    Minerva Med; 1982 Feb; 73(5):187-90. PubMed ID: 7038553
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Clinico-statistical study of medical treatment of hyperazotemic syndromes of prevalently dysmetabolic origin].
    Taglioretti D
    Minerva Urol; 1975; 27(3):127-31. PubMed ID: 1143239
    [No Abstract]   [Full Text] [Related]  

  • 6. [Pharmaco-metabolic activity in chronic hepatopathies: influence of treatment with UDPG].
    Okolicsànyi L; Orlando R; Lirussi F; Naccarato R; Dal Brun G
    Clin Ter; 1980 May; 93(4):431-8. PubMed ID: 6998643
    [No Abstract]   [Full Text] [Related]  

  • 7. [Clinical studies of the effect of a phosphorylated glycoderivative in acute viral hepatitis].
    Fiori GP; Mazza L
    Minerva Med; 1976 Mar; 67(12):132-40. PubMed ID: 1256689
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Hepatoprotective effect of a combination of UDPG, vitamin B 12 and liver extract in psychiatric patients with liver diseases].
    Castellani A; Colafelice M; Fichera M
    Clin Ter; 1978 Sep; 86(6):567-76. PubMed ID: 32989
    [No Abstract]   [Full Text] [Related]  

  • 9. [Controlled clinical trial of 2-mercapto-propionyl-glycine in chronic hepatopathies].
    Dioguardi N; Ideo G; De Franchis R; Ronchi G
    Minerva Med; 1976 Mar; 67(11):676-81. PubMed ID: 1256687
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antihepatotoxic properties of uridine-diphosphoglucose in liver fluke infection. Experimental fascioliasis in the rat.
    Maffei Facino R; Carini M; Genchi C; Tofanetti O; Casciarri I; Bedoschi D
    Arzneimittelforschung; 1990 Apr; 40(4):490-8. PubMed ID: 2113387
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Hepatoprotective drugs. Clinical results of the use of a sulfhydryl-methylating preparation].
    Rapino P; Marulli R; Rapex G; Della Lunga S; Sabatino P
    Minerva Med; 1982 Oct; 73(40):2853-60. PubMed ID: 7133498
    [No Abstract]   [Full Text] [Related]  

  • 12. [Galactose and antipyrine load tests in assessing the detoxification activity of the liver].
    Maestri G; D'Amore V; Angeli E
    Minerva Dietol Gastroenterol; 1979; 25(4):399-406. PubMed ID: 554030
    [No Abstract]   [Full Text] [Related]  

  • 13. [Therapy of acute and chronic liver diseases with combinations of vitamin B12 and anabolic hormones].
    Boeder KJ; Schmidt H; Khamsi A
    Med Welt; 1966 Apr; 14():730-4. PubMed ID: 5957304
    [No Abstract]   [Full Text] [Related]  

  • 14. [Prevention of neonatal jaundice with the administration of Toxepase Complex to pregnant women with edema-proteinuria-hypertension (EPH) gestosis].
    Cilotti R; Trincavelli M
    Minerva Ginecol; 1977 Mar; 29(3):233-44. PubMed ID: 577301
    [No Abstract]   [Full Text] [Related]  

  • 15. [Clinical experience report on Hepavis].
    Menninger U; Menninger W
    Med Welt; 1980 Oct; 31(42):1519-21. PubMed ID: 7453534
    [No Abstract]   [Full Text] [Related]  

  • 16. [Effectiveness of UDPG in the treatment of porphyria cutanea tarda. Preliminary findings].
    Okolicsanyi L; Orlando R; Busnardo F; Naccarato R; Veller-Fornasa C; Polin R
    Clin Ter; 1980 Sep; 94(6):687-94. PubMed ID: 7460503
    [No Abstract]   [Full Text] [Related]  

  • 17. [Study of bilirubin kinetics in a case of Dubin-Johnson syndrome before and after treatment with UDPG].
    Orlando R; Caregaro L; Muggeo M; Ghidini O; Okolicsanyi L
    Clin Ter; 1976 Feb; 76(4-3):323-32. PubMed ID: 971583
    [No Abstract]   [Full Text] [Related]  

  • 18. [Hepagrisevit forte in chronic liver diseases].
    Kollatz E; Kramer A; Schopper W; Siede W
    Med Klin; 1965 Dec; 60(50):2032-5. PubMed ID: 5331151
    [No Abstract]   [Full Text] [Related]  

  • 19. [Effect of UDPG on the surgical patient].
    Girotto T; Tinti S; Padovani G
    Minerva Anestesiol; 1975 Apr; 41(4):194-202. PubMed ID: 1186979
    [No Abstract]   [Full Text] [Related]  

  • 20. [Factors influencing the effect of ursodeoxycholic acid therapy in chronic hypertransaminasemia].
    Buongiorno G; Quaranta GM; Guerra V; Misciagna G; Manghisi OG
    Recenti Prog Med; 1992 May; 83(5):298-302. PubMed ID: 1439111
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.